Companion Diagnostics – Thematic Research

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Companion diagnostics (CDx) are molecular assays that measure levels of proteins, genes, or specific mutations to reveal a specific, efficacious therapy for an individual’s condition. CDx are a form of personalized, stratified, and precision medicine due to which a patient’s treatment will become increasingly individualized. CDx has expanded from a handful of oncology drugs with corresponding diagnostics to include multiple therapeutic areas, and the number of combinations has grown significantly over the years. However, oncology remains the largest segment for FDA-defined marketed drugs with CDx.

The CDx thematic research report looks at the CDx medical devices market and some of the oncology biomarkers, indications, and diagnostic technologies being utilized. The market for biomarker testing continues to increase due to increases in disease, awareness, improved accessibility to personalized medicine, and technological advancements.

What are the key techniques in CDx?

The key techniques used in CDx are immunohistochemistry (IHC), in situ hybridization (ISH), nucleic acid amplification (NAAT), and gene sequencing methods such as Sanger sequencing and next-generation sequencing (NGS).

Immunohistochemistry

IHC is a widely used, antibody-based technique that detects the presence of specific antigens or proteins in tissue. Frequently, chromogenic detection methods are used to visualize antibody-antigen interactions, allowing for the evaluation of cellular localization and staining patterns in the context of tumor structures.

In Situ Hybridization

ISH involves the denaturation of DNA or RNA to form single-stranded molecules, which naturally re-anneal to labelled probes made up of complementary nucleic acid sequences. Fluorescence in situ hybridization (FISH) uses probes that are directly labelled with fluorophores, antigens, or biotin. These are then subsequently bound by fluorescently tagged secondary compounds such as antibodies or streptavidin.

Nucleic Acid Amplification

A NAAT involves the amplification of specific nucleic acid sequences related to a target gene or mutation. NAATs invariably involve polymerase chain reaction (PCR) consisting of three main steps, which are repeated many times in cycles to amplify a target DNA sequence.

Sanger Sequencing

Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs).

Next-Generation Sequencing

NGS technology is increasingly being applied in clinical practice. The technique is highly scalable and typically involves fragmenting the genome and then randomly sampling for and sequencing these fragments. NGS can be performed on formalin-fixed and paraffin-embedded (FFPE) and freshly collected tissue specimens, as well as on fine-needle aspiration samples and small biopsy specimens.

What are the key trends in CDx?

The key trends in CDx are technology trends, macroeconomic trends, and regulatory trends. Technology trends include big data, artificial intelligence (AI), biomarker testing, laboratory developed tests, next-generation sequencing, and liquid biopsies. The decreasing cost of genetic testing as well as a collaboration between diagnostic and pharmaceutical companies come under macroeconomic trends. The impact of clinical guidelines is a part of regulatory trends.

Which are the key public companies associated with CDx?

Some of the key public companies associated with CDx are Abbott Laboratories, Agilent Technologies, bioMerieux, Illumina, and Thermo Fisher Scientific.

Which are the key private companies associated with CDx?

Some of the key private companies associated with CDx are Asuragen, Foundation Medicine, MilliporeSigma, and Roche Diagnostics International.

For more insights on this report, download a free report sample

Market report scope

Key techniques Immunohistochemistry (IHC), In Situ Hybridization (ISH), Nucleic Acid Amplification (NAAT), and Gene Sequencing Methods
Key public companies Abbott Laboratories, Agilent Technologies, bioMerieux, Illumina, and Thermo Fisher Scientific
Key private companies Asuragen, Foundation Medicine, MilliporeSigma, and Roche Diagnostics International

This report:

  • Identifies those companies most likely to succeed in a world filled with disruptive threats.
  • Predicts how each theme will evolve and identify the leading and disrupting companies.

Reasons to Buy

  • GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
  • Develop and design your corporate strategies through an in-house expert analysis of companion diagnostics by understanding the primary ways in which this theme is impacting the medical devices industry.
  • Stay up to date on the industry’s major players and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

Abbott
Roche
Sysmex
bioMérieux
Asuragen
Thermo Fisher Scientific
NimaGen
Illumina

Table of Contents

Players

Technology briefing

Trends

Industry analysis

Value chain

Companies

Further reading

Thematic methodology

Frequently asked questions

Companion Diagnostics – Thematic Research thematic reports
Currency USD
$995

Can be used by individual purchaser only

$1,995

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Companion Diagnostics – Thematic Research was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Companion Diagnostics – Thematic Research in real time.

  • Access a live Companion Diagnostics – Thematic Research dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.